Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with Crohn’s disease treated with IV Entyvio demonstrated considerable improvements in ...
Please provide your email address to receive an email when new articles are posted on . In this video, Jia Luo, MD, highlighted a phase 2 randomized study in non-small cell lung cancer presented at ...
BASKING RIDGE, N.J. -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced the presentation of two posters ...
CHICAGO -- Brensocatib (Brinsupri) appeared to have a disease-modifying effect on structural lung changes in non-cystic fibrosis bronchiectasis at its higher dose, a CT substudy of the ASPEN trial ...
The goal of the substudy is to evaluate the safety of biweekly IV Trappsol ® Cyclo™ (HPβCD) (2000 mg/kg) for 192 weeks in very young patients (birth to ≤ 3 years), in order to obtain descriptive data ...
A long-standing request to clarify data irregularities in a 2021 ISCHEMIA substudy resulted in the publication of one correction, with a second correction in the works. Further, the lone cardiac ...
EUROPA, the largest study ever conducted in patients with stable CAD, investigated the effect of perindopril 8 mg once daily added to standard therapy on cardiovascular events in 12,218 male or female ...
The ITALIC-RCC study: A randomized study of clinical and humoral impact of primary tumor ablation in metastatic renal cell carcinoma treated with immunotherapy. This is an ASCO Meeting Abstract from ...
(RTTNews) - Johnson & Johnson (JNJ) MedTech, Tuesday announced results from the VARIPURE substudy of SECURE, evaluating the VARIPULSE Platform in pulsed field ablation procedures for atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results